Contact this trialFirst, we need to learn more about you.
Anti-viral
Valacyclovir for Neonatal Herpes
Recruiting1 awardPhase 1
Charlotte, North Carolina
This trial is testing a new dose of valacyclovir for preventing neonatal herpes simplex virus (HSV). The initial dose will be 10ml/kg, and if it's safe and effective, eight more subjects will be enrolled at a higher dose.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.